FDA clears 6 more doses of Hospira's heparin

09/1/2009 | Forbes

The FDA is allowing Hospira to market six additional doses and concentrations of blood thinner heparin. The products will be available in three single-dose vials and three multiple-dose vials.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC